Takeda Pharma will acquire LigoCyte Pharmaceuticals for an upfront payment of US$60 million, it announced on Friday.
The Japanese Ministry of Health, Labor and Welfare has approved a New Drug Application of Lotriga granular capsule 2g for the treatment of hyperlipidemia in Japan.
Takeda Pharma announced yesterday the initiation of a Phase 3 clinical trial involving 400 patients across Japan, Hong Kong, South Korea, and Taiwan.
AZILVA, a new drug from Takeda Pharmaceutical Company Limited, is now available for the treatment of hypertension in Japan.
Takeda Farmacêutica Brasil Ltda., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, is set to acquire Brazil-based Multilab for US$250 million.
Takeda Pharma subsidiary Takeda America Holdings, Inc. is set to acquire Philadelphia-based URL Pharma for US$800 million.
Takeda Pharma has joined the Structural Genomics Consortium to fund collective drug research aimed at bringing new, more effective medicines to market faster.
Millennium today announced the initiation of an international Phase III clinical trial evaluating MLN8237 in patients with relapsed or refractory peripheral T-cell lymphoma.